Abstract
INTRODUCTION: Liver test elevations occur post-liver transplantation (LTx) secondary to a variety of etiologies including parenchymal, biliary or vascular dysfunction. Workup often includes a multi-step evaluation including imaging, liver biopsy and evaluation of the biliary system. Endoscopic ultrasound-guided fine needle biopsy of the liver (EUS-LB) is a novel technique that has been shown to be safe and effective. Herein, we report our experience with a single-session EUS-LB coupled with endoscopic retrograde cholangiopancreatography (ERCP) in the evaluation of abnormal liver function tests in the post-LTx population. METHODS: This is a retrospective analysis of electronic medical record over 2-year period (1/2017 – 5/2019). EUS-LB was performed in addition to ERCP for the evaluation and treatment of elevated liver tests and suspected biliary abnormality. EUS-LB was obtained using 19-gauge core biopsy needle (Sharkcore, Medtronic, Sunnyvale, CA. or Acquire, Boston Scientific, Marlborough, MA.) via modified one pass, one actuation wet suction technique. RESULTS: Thirty-nine patients underwent simultaneous EUS-LB and ERCP (mean age 52 ± 15 years; 62% female; mean BMI 27) after an average of 61 (1-432) weeks post-LTx. Nineteen patients (49%) were on aspirin. The mean EUS-LB and ERCP procedure time were 15 ± 12 and 21 ± 13 minutes respectively. EUS-LB was performed from a single lobe in 29 patients (74%) via 1 pass in 23 patients and 2 or 3 passes in the remainder. Ten patients (26%) underwent EUS-LB via 2 or 3 passes of both lobes. Adequate yield for histopathology in 37 of 39 (95%). Two specimens were inadequate due to defective needles. The mean specimen aggregate length was 30 ± 19 mm, longest intact core was 19 ± 11 mm and complete portal tracts were 16 ± 7.8. ERCP abnormalities were anastomotic stricture (33; 84.6%), debris (5; 12.8%), choledocholithiasis (4; 10.3%), and biliary leak (2; 5.1%). Histology demonstrated acute rejection (10; 27.0%), cholestasis (11; 29.7%), non-specific hepatitis (12; 32.4%), chronic rejection (2; 5.4%), and alcoholic hepatitis (1; 2.7%). Procedural complications were pancreatitis (2; 5.1%), cholangitis due to occluded stent (1; 2.6%), and hematoma requiring transfusion but no intervention (1; 2.6%). CONCLUSION: Simultaneous EUS-LB and ERCP evaluation of post-LTx patients is an effective technique for the assessment of abnormal liver function tests, obviating the need for separate evaluations with potential delays of care and prolonged hospitalization.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have